Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies

Published 2014 View Full Article

Authors

Keywords

Journal

CLINICAL THERAPEUTICS

Volume 36, Issue 12, Pages 1958-1971

Publisher

Elsevier BV

Online

2014-10-13

DOI

10.1016/j.clinthera.2014.08.013

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL THERAPEUTICS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.